Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 24, 2007 - Issue 3
889
Views
107
CrossRef citations to date
0
Altmetric
Original

Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study

&
Pages 521-537 | Received 17 Jun 2006, Accepted 02 Oct 2006, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Giovanni Camardese, Beniamino Leone, Riccardo Serrani, Coco Walstra, Marco Di Nicola, Giacomo Della Marca, Pietro Bria & Luigi Janiri. (2015) Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients. Neuropsychiatric Disease and Treatment 11, pages 2331-2338.
Read now
Pedro Lax, Gema Esquiva, Julian Esteve-Rudd, Beatriz Baño Otalora, Juan Antonio Madrid & Nicolás Cuenca. (2012) Circadian Dysfunction in a Rotenone-Induced Parkinsonian Rodent Model. Chronobiology International 29:2, pages 147-156.
Read now
Francesco Portaluppi, Pietro Cortelli, Giovanna Calandra Buonaura, Michael H Smolensky & Fabio Fabbian. (2009) DO RESTLESS LEGS SYNDROME (RLS) AND PERIODIC LIMB MOVEMENTS OF SLEEP (PLMS) PLAY A ROLE IN NOCTURNAL HYPERTENSION AND INCREASED CARDIOVASCULAR RISK OF RENALLY IMPAIRED PATIENTS?. Chronobiology International 26:6, pages 1206-1221.
Read now
Roseanne DeFronzo Dobkin, Matthew Menza & Karina L Bienfait. (2008) CBT for the treatment of depression in Parkinson’s disease: a promising nonpharmacological approach. Expert Review of Neurotherapeutics 8:1, pages 27-35.
Read now
Francesco Portaluppi, Yvan Touitou & Michael H. Smolensky. (2008) Ethical and Methodological Standards for Laboratory and Medical Biological Rhythm Research. Chronobiology International 25:6, pages 999-1016.
Read now
Bernard Bruguerolle. (2008) Clinical Chronopharmacology in the Elderly. Chronobiology International 25:1, pages 1-15.
Read now

Articles from other publishers (101)

Beatrix Feigl, Simon J. G. Lewis & Oliver Rawashdeh. (2023) Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease. Journal of Neurology.
Crossref
Seyedeh Marzieh Hosseini, Sajjad Farashi & Saeid Bashirian. (2023) Electromagnetic radiation therapy for Parkinson’s disease tremor reduction- systematic reviews and Bayesian meta-analyses for comparing the effectiveness of electric, magnetic and light stimulation methods. Journal of NeuroEngineering and Rehabilitation 20:1.
Crossref
Gregory L. Willis & Stuart M. Armstrong. (2023) Fine-tuning the circadian system with light treatment for Parkinson’s disease: an in-depth, critical review. Reviews in the Neurosciences 0:0.
Crossref
Katarzyna Smilowska, Daniel J. van Wamelen & Bastiaan R. Bloem. (2023) The multimodal effect of circadian interventions in Parkinson's disease: A narrative review. Parkinsonism & Related Disorders 110, pages 105309.
Crossref
Duttagupta Subhadeep, B. N. Srikumar, B. S. Shankaranarayana Rao & Bindu M. Kutty. 2023. Sleep and Clocks in Aging and Longevity. Sleep and Clocks in Aging and Longevity 349 361 .
Yoonha Hwang. (2022) Circadian Rhythms in Parkinson’s Disease. Chronobiology in Medicine 4:4, pages 137-140.
Crossref
Yanli Zhu, Yanqing Liu, Germaine Escames, Zhi Yang, Huadong Zhao, Lu Qian, Chengxu Xue, Danni Xu, Darío Acuña-Castroviejo & Yang Yang. (2022) Deciphering clock genes as emerging targets against aging. Ageing Research Reviews 81, pages 101725.
Crossref
Qiling Ji, Xuemei Wang, Wenbo Zhao, Melissa Wills, Ho Jun Yun, Yanna Tong, Lipeng Cai, Xiaokun Geng & Yuchuan Ding. (2022) Effects of remote ischemic conditioning on sleep complaints in Parkinson's disease–rationale, design, and protocol for a randomized controlled study. Frontiers in Neurology 13.
Crossref
Wai-Yin Cheng, Yuen-Shan Ho & Raymond Chuen-Chung Chang. (2022) Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases. Ageing Research Reviews 78, pages 101620.
Crossref
Müge Yalçin, Annakarina Mundorf, Freya Thiel, Sandra Amatriain-Fernández, Ida Schulze Kalthoff, Jan-Carl Beucke, Henning Budde, Susan Garthus-Niegel, Jutta Peterburs & Angela Relógio. (2022) It’s About Time: The Circadian Network as Time-Keeper for Cognitive Functioning, Locomotor Activity and Mental Health. Frontiers in Physiology 13.
Crossref
Malik Nassan & Aleksandar Videnovic. (2021) Circadian rhythms in neurodegenerative disorders. Nature Reviews Neurology 18:1, pages 7-24.
Crossref
Bruce I. Gaynes, Adnaan Zaffer, Raman Yousefzai, Mario Chazaro-Cortes, Kalea Colletta, Sandra L. Kletzel, Mary Beth Jost, Youngsook Park, Jasvinder Chawla, Mark V. Albert & Ting Xiao. (2021) Variable abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson’s disease (PD) and parkinsonism features. Neurological Sciences 43:1, pages 349-356.
Crossref
Hsu-Tung Huang, Tsai-Wei Huang & Chien-Tai Hong. (2021) Bright Light Therapy for Parkinson Disease: A Literature Review and Meta-Analysis of Randomized Controlled Trials. Biology 10:11, pages 1205.
Crossref
Aqsa Ullah, Mays Alani, Omar Chaudry, Afra Janarious, Nina Tsakadze, Michele Nunes, Umesh Sharma, Lourdes Benes-Lima, Elisa Marie Rossi, Carlyn Rodriguez-Nazario & Fabian Rossi. 2021. Updates in Sleep Neurology and Obstructive Sleep Apnea. Updates in Sleep Neurology and Obstructive Sleep Apnea.
Fabin Lin, Yixiao Su, Yanhong Weng, Xiaofeng Lin, Huidan Weng, Guofa Cai & Guoen Cai. (2021) The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. Sleep Medicine 83, pages 280-289.
Crossref
Santiago Pérez-Lloret & Daniel P. Cardinali. (2021) Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease. Frontiers in Pharmacology 12.
Crossref
Rina S. Fox, Sharon H. Baik, Heather McGinty, Sofia F. Garcia, Kathryn J. Reid, Katrin Bovbjerg, Precilla Fajardo, Lisa M. Wu, Shohreh Shahabi, Jason C. Ong, Phyllis C. Zee & Frank J. Penedo. (2020) Feasibility and Preliminary Efficacy of a Bright Light Intervention in Ovarian and Endometrial Cancer Survivors. International Journal of Behavioral Medicine 28:1, pages 83-95.
Crossref
Zanna J. Voysey, Roger A. Barker & Alpar S. Lazar. (2020) The Treatment of Sleep Dysfunction in Neurodegenerative Disorders. Neurotherapeutics 18:1, pages 202-216.
Crossref
John C. Carter & Vishesh K. Kapur. 2021. Sleep Neurology. Sleep Neurology 269 287 .
Marissa N. Dean & Amy W. Amara. 2021. Clinical Trials In Parkinson's Disease. Clinical Trials In Parkinson's Disease 271 291 .
José Rafael P. Zuzuárregui & Emmanuel H. During. (2020) Sleep Issues in Parkinson’s Disease and Their Management. Neurotherapeutics 17:4, pages 1480-1494.
Crossref
Hikmat Hadoush, Tamara Lababneh, Saleem A. Banihani, Muhammed Al-Jarrah & Mohammed Jamous. (2020) Melatonin and dopamine serum level associations with motor, cognitive, and sleep dysfunctions in patients with Parkinson’s disease: A cross-sectional research study. NeuroRehabilitation 46:4, pages 539-549.
Crossref
Yu Chen Chang & Jin Young Kim. (2019) Therapeutic implications of circadian clocks in neurodegenerative diseases. Journal of Neuroscience Research 98:6, pages 1095-1113.
Crossref
Priti Gros & Aleksandar Videnovic. (2020) Overview of Sleep and Circadian Rhythm Disorders in Parkinson Disease. Clinics in Geriatric Medicine 36:1, pages 119-130.
Crossref
Gregory L. Willis. 2020. Diagnosis and Management in Parkinson's Disease. Diagnosis and Management in Parkinson's Disease 107 123 .
Guo-Dong Huang & Ya-Li Wang. 2020. Sleep Disorders in Parkinson’s Disease. Sleep Disorders in Parkinson’s Disease 83 100 .
Aliza K. De Nobrega, Kristine V. Luz & Lisa C. Lyons. 2020. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders 193 265 .
Koliane Ouk, Juliet Aungier, Michelle Ware & A. Jennifer Morton. (2019) Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light. eneuro 6:6, pages ENEURO.0088-19.2019.
Crossref
Temitayo Oyegbile & Aleksandar Videnovic. (2019) Irregular Sleep-Wake Rhythm Disorder. Neurologic Clinics 37:3, pages 553-561.
Crossref
Roberto Maggio, Francesca Vaglini, Mario Rossi, Irene Fasciani, Ilaria Pietrantoni, Francesco Marampon, Giovanni U. Corsini, Marco Scarselli & Mark J. Millan. (2019) Parkinson’s disease and light: The bright and the Dark sides. Brain Research Bulletin 150, pages 290-296.
Crossref
Daniel P. Cardinali. (2019) Melatonin: Clinical Perspectives in Neurodegeneration. Frontiers in Endocrinology 10.
Crossref
Sonja Rutten, Chris VriendJan H. SmitHenk W. BerendseEus J.W. van SomerenAdriaan W. HoogendoornJos W. R. TwiskYsbrand D. van der WerfOdile A. van den Heuvel. (2019) Bright light therapy for depression in Parkinson disease. Neurology 92:11.
Crossref
Aleksandar VidenovicLambros Messinis. (2019) Enlightened PD. Neurology 92:11, pages 499-500.
Crossref
Karim Fifel & Aleksandar Videnovic. (2019) Chronotherapies for Parkinson’s disease. Progress in Neurobiology 174, pages 16-27.
Crossref
M.A. Tolentino & J.A. Lyons. 2019. Photobiomodulation in the Brain. Photobiomodulation in the Brain 241 251 .
Wout van BommelWout van Bommel. 2019. Interior Lighting. Interior Lighting 221 232 .
Gregory L. Willis, Jamilee Boda & Christopher B. Freelance. (2018) Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory Trial. Frontiers in Neurology 9.
Crossref
JuHee Lee, Yonji Kim & Yie Lin Kim. (2018) Non-pharmacological therapies for sleep disturbances in people with Parkinson's disease: A systematic review. Journal of Advanced Nursing 74:8, pages 1741-1751.
Crossref
B. S. Alghamdi. (2018) The neuroprotective role of melatonin in neurological disorders. Journal of Neuroscience Research 96:7, pages 1136-1149.
Crossref
Aleksandar Videnovic. (2018) Disturbances of Sleep and Alertness in Parkinson’s Disease. Current Neurology and Neuroscience Reports 18:6.
Crossref
Karim Fifel & Aleksandar Videnovic. (2018) Light Therapy in Parkinson’s Disease: Towards Mechanism-Based Protocols. Trends in Neurosciences 41:5, pages 252-254.
Crossref
Jessica K. Martino, Christopher B. Freelance & Gregory L. Willis. (2018) The effect of light exposure on insomnia and nocturnal movement in Parkinson's disease: an open label, retrospective, longitudinal study. Sleep Medicine 44, pages 24-31.
Crossref
Bibet L. ten Harmsen, Anouke van Rumund, Marjolein B. Aerts, Mayra I. Bergkamp, Rianne A.J. Esselink, Edo Richard, Frederick J.A. Meijer, Bastiaan R. Bloem & Daniel J. van Wamelen. (2018) Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease. Parkinsonism & Related Disorders 49, pages 28-33.
Crossref
Xiaotao Li & Xiang Li. (2018) The Antidepressant Effect of Light Therapy from Retinal Projections. Neuroscience Bulletin 34:2, pages 359-368.
Crossref
Gregory L. Willis & Christopher B. Freelance. (2018) The effect of intravitreal cholinergic drugs on motor control. Behavioural Brain Research 339, pages 232-238.
Crossref
Fan Lou, Ming Li, Xiaoguang Luo & Yan Ren. (2018) CLOCK 3111T/C Variant Correlates with Motor Fluctuation and Sleep Disorders in Chinese Patients with Parkinson’s Disease. Parkinson's Disease 2018, pages 1-6.
Crossref
Gregory L. Willis & Christopher B. Freelance. (2018) Emerging preclinical interest concerning the role of circadian function in Parkinson’s disease. Brain Research 1678, pages 203-213.
Crossref
Gregory L. Willis & Christopher B. Freelance. (2017) The effect of directed photic stimulation of the pineal on experimental Parkinson's disease. Physiology & Behavior 182, pages 1-9.
Crossref
Yan Li, Shu-Mei Wang, Lei Guo, Jian Zhu, Ying Wang, Lei Li & Yan-Xin Zhao. (2017) Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease. Chinese Medical Journal 130:22, pages 2726-2731.
Crossref
Priti Gros & Aleksandar Videnovic. (2017) Sleep and Circadian Rhythm Disorders in Parkinson’s Disease. Current Sleep Medicine Reports 3:3, pages 222-234.
Crossref
Gregory L. Willis & Christopher B. Freelance. (2017) Neurochemical Systems of the Retina Involved in the Control of Movement. Frontiers in Neurology 8.
Crossref
Amy W. Amara, Lana M. Chahine & Aleksandar Videnovic. (2017) Treatment of Sleep Dysfunction in Parkinson’s Disease. Current Treatment Options in Neurology 19:7.
Crossref
Aleksandar Videnovic. (2017) Management of sleep disorders in Parkinson's disease and multiple system atrophy. Movement Disorders 32:5, pages 659-668.
Crossref
Eduardo De Pablo-Fernández, David P Breen, Pierre M Bouloux, Roger A Barker, Thomas Foltynie & Thomas T Warner. (2017) Neuroendocrine abnormalities in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 88:2, pages 176-185.
Crossref
Siyue Li, Yali Wang, Fen Wang, Li-Fang Hu & Chun-Feng Liu. (2016) A New Perspective for Parkinson’s Disease: Circadian Rhythm. Neuroscience Bulletin 33:1, pages 62-72.
Crossref
Huei-Bin Wang, Daniel S. Whittaker, Danny Truong, Aly K. Mulji, Cristina A. Ghiani, Dawn H. Loh & Christopher S. Colwell. (2017) Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease. Neurobiology of Sleep and Circadian Rhythms 2, pages 39-52.
Crossref
Erik S. Musiek & Aleksandar Videnovic. (2017) Sleep and clocks – implications for brain health. Neurobiology of Sleep and Circadian Rhythms 2, pages 1-3.
Crossref
Koliane Ouk, Juliet Aungier & A. Jennifer Morton. (2017) Prolonged day length exposure improves circadian deficits and survival in a transgenic mouse model of Huntington's disease. Neurobiology of Sleep and Circadian Rhythms 2, pages 27-38.
Crossref
Aleksandar Videnovic & Diego Golombek. (2017) Circadian dysregulation in Parkinson's disease. Neurobiology of Sleep and Circadian Rhythms 2, pages 53-58.
Crossref
PaulF Seke Etet, Mohammed Farahna, MaherA.M. Khayr, KhalidM Omar, ÖmürG Deniz, HeshamN Mustafa, NadiaO Alatta, Abdulmonem Alhayani, Süleyman Kaplan & Lorella Vecchio. (2017) Evaluation of the safety of conventional lighting replacement by artificial daylight. Journal of Microscopy and Ultrastructure 5:4, pages 206.
Crossref
Sabra M. Abbott, Roneil G. Malkani & Phyllis C. Zee. 2017. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine 405 413.e6 .
Koliane Ouk, Steven Hughes, Carina A. Pothecary, Stuart N. Peirson & A. Jennifer Morton. (2016) Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington’s disease. Human Molecular Genetics, pages ddw359.
Crossref
Sonja Rutten, Chris Vriend, Jan H. Smit, Henk W. Berendse, Adriaan W. Hoogendoorn, Odile A. van den Heuvel & Ysbrand D. van der Werf. (2016) A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson’s disease. BMC Psychiatry 16:1.
Crossref
Yu. V. Ukraintseva & V. M. Kovalzon. (2016) Circadian regulation and its disorders in Parkinson’s disease patients. Part 2: Experimental models, alpha-synuclein, and melatonin. Human Physiology 42:5, pages 559-570.
Crossref
Tiago Martins Rodrigues, Ana Castro Caldas & Joaquim J. Ferreira. (2016) Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis. Parkinsonism & Related Disorders 27, pages 25-34.
Crossref
Aleksandar Videnovic & Gregory L. Willis. (2016) Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?. Movement Disorders 31:3, pages 260-269.
Crossref
Josiel Mileno Mack, Marissa Giovanna Schamne, Tuane Bazanella Sampaio, Renata Aparecida Nedel Pértile, Pedro Augusto Carlos Magno Fernandes, Regina P. Markus & Rui Daniel Prediger. (2016) Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms. Oxidative Medicine and Cellular Longevity 2016, pages 1-31.
Crossref
Santiago Perez-Lloret, Darío Acuña-Castroviejo, Victor Demaria-Pesce & Daniel Cardinali. 2016. Dopamine and Sleep. Dopamine and Sleep 91 114 .
Daniel J van Wamelen, Raymund AC Roos & Nasir A Aziz. (2015) Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease. Neurodegenerative Disease Management 5:6, pages 549-559.
Crossref
Roneil Malkani & Hrayr Attarian. (2015) Sleep in Neurodegenerative Disorders. Current Sleep Medicine Reports 1:2, pages 81-90.
Crossref
Megan A. Miller, Regina L. Leckie, Shannon D. Donofry, Peter J. Gianaros, Kirk I. Erickson, Stephen B. Manuck & Kathryn A. Roecklein. (2015) Photoperiod is associated with hippocampal volume in a large community sample. Hippocampus 25:4, pages 534-543.
Crossref
Hiroki Hirano, Masafumi Ito, Takuyuki Endo, Hideaki Hayashi, Harutoyo Hirano, Yuichi Kurita, Saburo Sakoda & Toshio Tsuji. (2015) A diagnostic support method for evaluating autonomic nervous function of patients with Parkinson's disease using a head-up tilt test. Iryou kikigaku (The Japanese journal of medical instrumentation) 85:6, pages 569-576.
Crossref
Aleksandar Videnovic. 2015. Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Disorders of Sleep and Circadian Rhythms in Parkinson's Disease 117 129 .
Aleksandar Videnovic, Alpar S. Lazar, Roger A. Barker & Sebastiaan Overeem. (2014) 'The clocks that time us'—circadian rhythms in neurodegenerative disorders. Nature Reviews Neurology 10:12, pages 683-693.
Crossref
. (2014) Clinical Roundup: Selected Treatment Options for Parkinson’s Disease. Alternative and Complementary Therapies 20:3, pages 157-162.
Crossref
Marc Cuesta, Juliet Aungier & A. Jennifer Morton. (2014) Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease. Neurobiology of Disease 63, pages 85-91.
Crossref
Gregory L. Willis, Cleo Moore & Stuart Maxwell Armstrong. (2014) Parkinson's Disease, Lights and Melanocytes: Looking Beyond the Retina. Scientific Reports 4:1.
Crossref
Venkataramanujam Srinivasan, U. S. Srinivasan, Charanjit Kaur, Rahimah Zakaria, Zahiruddin Othman, Edward C. Lauterbach & Dario Acuña-Castroviejo. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice 249 261 .
Yevgeny Botanov & Stephen S. Ilardi. (2013) The Acute Side Effects of Bright Light Therapy: A Placebo-Controlled Investigation. PLoS ONE 8:9, pages e75893.
Crossref
Aleksandar Videnovic & Diego Golombek. (2013) Circadian and sleep disorders in Parkinson's disease. Experimental Neurology 243, pages 45-56.
Crossref
Seithikurippu R. Pandi-Perumal, Ahmed S. BaHammam, Gregory M. Brown, D. Warren Spence, Vijay K. Bharti, Charanjit Kaur, Rüdiger Hardeland & Daniel P. Cardinali. (2012) Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes. Neurotoxicity Research 23:3, pages 267-300.
Crossref
Daryl J. Victor, Jack Janani & Steven Frucht. 2013. Parkinson’s Disease and Nonmotor Dysfunction. Parkinson’s Disease and Nonmotor Dysfunction 267 290 .
A. Carpentieri, G. Díaz de Barboza, V. Areco, M. Peralta López & N. Tolosa de Talamoni. (2012) New perspectives in melatonin uses. Pharmacological Research 65:4, pages 437-444.
Crossref
Nico J. Diederich & Deborah J. McIntyre. (2012) Sleep disorders in Parkinson's disease: Many causes, few therapeutic options. Journal of the Neurological Sciences 314:1-2, pages 12-19.
Crossref
Martina Pfeffer, Stefanie Plenzig, Suzana Gispert, Keiji Wada, Horst-Werner Korf & Charlotte Von Gall. (2012) Disturbed sleep/wake rhythms and neuronal cell loss in lateral hypothalamus and retina of mice with a spontaneous deletion in the ubiquitin carboxyl-terminal hydrolase L1 gene. Neurobiology of Aging 33:2, pages 393-403.
Crossref
Sonja Rutten, Chris Vriend, Odile A. van den Heuvel, Jan H. Smit, Henk W. Berendse & Ysbrand D. van der Werf. (2012) Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence. Parkinson's Disease 2012, pages 1-9.
Crossref
Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence, Rüdiger Hardeland & Seithikurippu R. Pandi-Perumal. (2011) Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection. Therapeutic Advances in Neurological Disorders 4:5, pages 297-317.
Crossref
George Zhong, Sharon Linda Naismith, Naomi Louise Rogers & Simon John Geoffrey Lewis. (2011) Sleep–wake disturbances in common neurodegenerative diseases: A closer look at selected aspects of the neural circuitry. Journal of the Neurological Sciences 307:1-2, pages 9-14.
Crossref
Anne-Marie Gagné, Frédéric Lévesque, Philippe Gagné & Marc Hébert. (2011) Impact of blue vs red light on retinal response of patients with seasonal affective disorder and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:1, pages 227-231.
Crossref
Sharon L. Naismith, Simon J.G. Lewis & Naomi L. Rogers. 2011. Human Sleep and Cognition Part II - Clinical and Applied Research. Human Sleep and Cognition Part II - Clinical and Applied Research 21 52 .
Antonio Pirodda, Maria Chiara Raimondi & Gian Gaetano Ferri. (2010) Exploring the reasons why melatonin can improve tinnitus. Medical Hypotheses 75:2, pages 190-191.
Crossref
G. L. Willis & S. M. Armstrong. (2010) New Vistas on Parkinson’s disease. European Journal of Neurology 17:4, pages 519-520.
Crossref
Aleksandar Videnovic & Cynthia L. Comella. 2010. Principles and Practice of Geriatric Sleep Medicine. Principles and Practice of Geriatric Sleep Medicine 195 213 .
Theresa A. Zesiewicz & Marian L. Evatt. (2009) Potential Influences of Complementary Therapy on Motor and Non-Motor Complications in Parkinsonʼs Disease. CNS Drugs 23:10, pages 817-835.
Crossref
Nico J. Diederich, Gilles Fénelon, Glenn Stebbins & Christopher G. Goetz. (2009) Hallucinations in Parkinson disease. Nature Reviews Neurology 5:6, pages 331-342.
Crossref
Renee Monderer & Michael Thorpy. (2009) Sleep disorders and daytime sleepiness in Parkinson’s disease. Current Neurology and Neuroscience Reports 9:2, pages 173-180.
Crossref
Gregory L. Willis, Adelheid M.A. Kelly & Gerard A. Kennedy. (2008) Compromised circadian function in Parkinson's disease: Enucleation augments disease severity in the unilateral model. Behavioural Brain Research 193:1, pages 37-47.
Crossref
Cynthia L. Comella. (2008) Sleep Disorders in Parkinson's Disease. Sleep Medicine Clinics 3:3, pages 325-335.
Crossref
Gregory L. Willis. (2008) Intraocular microinjections repair experimental Parkinson's disease. Brain Research 1217, pages 119-131.
Crossref
Cynthia L. Comella. (2008) Sleep disorders in Parkinson’s disease. Current Treatment Options in Neurology 10:3, pages 215-221.
Crossref
Michael Terman. (2007) Evolving applications of light therapy. Sleep Medicine Reviews 11:6, pages 497-507.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.